Universal Endometrial Cancer DNA Sequencing for Detection of Lynch Syndrome and Personalized Care
Ontology highlight
ABSTRACT: This clinical trial studies universal screening for deoxyribonucleic acid (DNA) mismatch repair deficiency in patients with endometrial cancer, mutations in the genes responsible for Lynch syndrome (inherited forms of endometrial cancers) and other DNA changes that could help guide treatment strategies. Universal tumor DNA sequencing may help doctors better understand how to personalize care, increase length of life, and increase quality of life in patients with endometrial cancer and their relatives.
DISEASE(S): Lynch Syndrome,Endometrial Adenocarcinoma,Relatives,Endometrial Neoplasms,Colorectal Neoplasms, Hereditary Nonpolyposis,Endometrial Carcinoma
PROVIDER: 2267967 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA